Showing results (151-160 of 267) with videos related to
Sort By:
Pageof 27
The Journal of Infection|February 25, 2019
Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumoniaJosé Luis Piñana, Estela Giménez, María Dolores Gómez, et al.Blood|March 22, 2014
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantationJan M Middeke, Min Fang, Jan J Cornelissen, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 12, 2017
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosisBonaventura Casanova, Isidro Jarque, Francisco Gascón, et al.Transplantation and Cellular Therapy|May 10, 2026
Secondary Malignancies after Hematopoietic Stem Cell TransplantationPedro Asensi Cantó, Miguel Mansilla-Polo, Juan Montoro, et al.Bone Marrow Transplantation|September 22, 2022
Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)Eleni Gavriilaki, Myriam Labopin, Ioanna Sakellari, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2025
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 TrialMohamad Mohty, Gerard Socié, Jeff Szer, et al.AIDS (London, England)|April 2, 2019
Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disordersMi Kwon, Rebeca Bailén, Pascual Balsalobre, et al.Leukemia|July 24, 2024
Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamideSimona Piemontese, Myriam Labopin, Goda Choi, et al.The Lancet. Haematology|December 31, 2021
Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trialRobert Zeiser, Gérard Socié, Mark A Schroeder, et al.Bone Marrow Transplantation|June 25, 2024
Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experienceMiguel Ángel Sanz, Juan Montoro, Aitana Balaguer-Roselló, et al.Pageof 27